Abbott Laboratories
ABT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000001800
In the last 90 days, Abbott Laboratories insiders filed 0 open-market purchases and 3 sales; 2,985 institutions reported holding it in 13F filings for Q2 2026, worth $125.5B in total; 3 superinvestors hold it, including Southeastern Asset Management (Longleaf) and Soros Fund Management.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $46.9M in total
- 3
- 13F holdersQ2 2026, −90 vs. previous quarter
- 2,985
- 13F valueReported value at the end of Q2 2026
- $125.5B
- Superinvestors holdingAt the end of Q2 2026
- 3
Price chart
Superinvestors holding ABT, Q2 2026
3 superinvestors report holding Abbott Laboratories on Form 13F. Percentages are the stock's share of each portfolio.
Southeastern Asset Management (Longleaf)
Mason Hawkins
4.0%
Abbott Laboratories's share of the portfolio
- Shares
- 840,747
- Value
- $76.3M
Soros Fund Management
George Soros
0.1%
Abbott Laboratories's share of the portfolio
- Shares
- 44,750
- Value
- $4.06M
| Superinvestor | Weight | Value |
|---|---|---|
| Gardner Russo & Quinn | <0.1% | $1.04M |
Latest insider trades
Open-market purchases and sales by Abbott Laboratories insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 (view filing)6:11 PM ET | Sep 2 | 1 day | McCoy John A. Jr.VICE PRESIDENT AND CONTROLLER | SSaleCommon shares without par value | −27 | $109.54 | −$2.96K | −0.1%24.5K after | |
| Aug 27, 2026 (view filing)5:09 PM ET | Aug 25 | 2 days | Ford Robert BCHAIRMAN AND CEO | SSaleCommon shares without par value | −398.8K | $115.85 | −$46.2M | −56.5%306.5K after | 2 lots |
| Aug 13, 2026 (view filing)5:14 PM ET | Aug 11 | 2 days | Morrone Louis H.EXECUTIVE VICE PRESIDENT | SSaleCommon shares without par value | −5.85K | $109.83 | −$642.5K | −7.6%70.7K after | |
| Jun 18, 2026 (view filing) | May 7 | 42 daysLate | Stratton John GDirector | PPurchaseCommon shares without par value | +2.00K | $86.82 | +$173.6K | +9.4%23.3K after | |
| Apr 28, 2026 (view filing) | Apr 27 | 1 day | Starks Daniel JDirector | PPurchaseCommon shares without par value | +10.0K | $92.65 | +$926.5K | +0.1%6.75M after | |
| Apr 27, 2026 (view filing) | Apr 23 | 4 days | Boudreau Philip PEVP AND CFO | PPurchaseCommon shares without par value | +2.20K | $91.50 | +$201.3K | New position2.20K after | |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Cushman Elizabeth C.EVP, GC AND SECRETARY | SSaleCommon shares without par value | −263 | $115.58 | −$30.4K | −0.7%38.6K after | |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Shroff EricSenior Vice President | SSaleCommon shares without par value | −709 | $115.58 | −$81.9K | −1.8%39.2K after | |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Morrone Louis H.EXECUTIVE VICE PRESIDENT | SSaleCommon shares without par value | −1.14K | $115.58 | −$132.2K | −1.5%76.8K after | |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Moreland Mary KEXECUTIVE VICE PRESIDENT | SSaleCommon shares without par value | −613 | $115.58 | −$70.9K | −0.6%104.3K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Abbott Laboratories at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 152,563,476 | $13.8B | 0.21% | +6,876,018+4.7% | Added |
| Vanguard Capital Management LLC | 113,750,994 | $10.3B | 0.22% | +801,061+0.7% | Added |
| State Street Corp | 80,926,234 | $7.34B | 0.22% | +1,350,766+1.7% | Added |
| Charles Schwab Investment Management Inc | 59,674,507 | $5.41B | 0.72% | +14,174,452+31.2% | Added |
| Vanguard Portfolio Management LLC | 49,017,866 | $4.45B | 0.20% | +1,072,975+2.2% | Added |
| Geode Capital Management, LLC | 39,219,337 | $3.54B | 0.19% | +70,542+0.2% | Added |
| Capital Research Global Investors | 36,908,990 | $3.35B | 0.47% | −12,866,372−25.8% | Reduced |
| Capital International Investors | 34,654,113 | $3.15B | 0.65% | −2,844,114−7.6% | Reduced |
| Morgan Stanley | 26,611,315 | $2.41B | 0.13% | −3,490,281−11.6% | Reduced |
| Norges Bank | 23,354,911 | $2.12B | 0.21% | +23,354,911 | New |